External Validation of a Machine Learning Classifier for Motor Progression in Parkinson’s Disease
Objective: To externally validate a previously published machine learning (ML) classifier for predicting motor symptom progression in Parkinson’s disease (PD) using an independent clinical dataset.…5-year Longitudinal Changes in Non-motor Symptoms and Their Association With Motor Progression in Parkinson’s Disease
Objective: To examine longitudinal relationships between non-motor symptoms (NMS) and motor progression in Parkinson’s disease (PD), and to determine whether baseline NMS predict motor decline…Clinical feasibility of a semi-automated Olfactometry System in α-Synucleinopathies
Objective: To evaluate the feasibility, performance, and diagnostic accuracy of a semi-automated olfactometry system (NOS-DX1000) for standardized assessment of olfactory dysfunction in α-synucleinopathies. Background: Olfactory…Temporally Patterned Deep Brain Stimulation Improves Gait Metrics and Freezing of Gait in Parkinson’s Disease
Objective: To investigate the clinical impact of temporally patterned deep brain stimulation (DBS) on gait and Freezing of Gait (FoG) in Parkinson’s disease (PD). Background:…Parkinson’s Disease and Parkinsonism Family Center Psychoeducational Program for Patients and Caregivers
Objective: To provide structured psychoeducational and informational support, including disease education, coping and self-management strategies, and guidance on healthcare and social services for Parkinson’s disease…Tongue Shape Complexity in Cantonese Parkinsonian Speech
Objective: To investigate tongue shape complexity across three consonants (/t/, /k/, /s/) in Cantonese people with Parkinson’s disease (PD) using ultrasound tongue imaging (UTI). Background: Articulatory…Complications Following Deep Brain Stimulation in Parkinson’s Disease: Single-centre Experience (2009-2025)
Objective: To evaluate the frequency and trends of DBS-related intraoperative, perioperative, and postoperative complications, and changes in disease duration at implantation over time. Background: Deep…Speech And Gait In Newly Diagnosed Parkinson’s Disease: Support For Early Rehabilitation
Objective: To describe the prevalence of self-reported speech difficulties in newly diagnosed Parkinson’s disease (PD) and to explore its associations with dysphagia, hypersalivation (HS) and…Association of Serum Linoleic Acid-containing Plasmalogens With Parkinson’s Disease: the PPMI Study
Objective: To investigate the associations of serum ethanolamine plasmalogens (PlsEtns) with Parkinson’s disease (PD) diagnosis and motor progression. Background: Altered plasmalogen levels have been reported…Peripheral neuropathy (NP) in advanced Parkinson’s disease (PD) patients treated with continuous subcutaneous foslevodopa/foscarbidopa (fLD/fCD)
Objective: To assess peripheral NP occurrence and clinico-electrophysiological features in patients with advanced PD patients treated with continuous subcutaneous fLD/fCD. Background: Continuous subcutaneous fLD/fCD is effective…
- « Previous Page
- 1
- …
- 16
- 17
- 18
- 19
- 20
- …
- 553
- Next Page »